Strike selection is the second required skill when writing covered call options or selling cash-secured puts. Over the years I have been asked to suggest a specific Delta for strike selection implying that this statistic would be the sole criterion to determine strike determination. This article will make a case why Delta, although important, should […]
Rolling Up in the Same Contract Month: A Real-Life Example with KMX
Position management or exit strategies for covered call writing and selling puts is the third required skill to achieve the highest possible return levels (stock and option selection are the first two). First, we must determine if an exit strategy opportunity actually exists and then, if so, which one to execute. On May 3rd 2019, […]
Ask Alan #163 – Timing Our Covered Call Trades in Bull Markets
Alan answers a question posed by Phil, who asks: Alan,Alan, In bull markets, isn’t it a good idea to buy stocks, wait for appreciation and then selling covered call? This way we can take advantage of market conditions. Thanks. Phil ——— It’s the 2nd Wednesday of the month. Time for another original episode of Ask […]
Rolling Deep OTM Puts to a Higher Strike: A Viable Mid-Contract Strategy?
After selling an out-of-the-money (OTM) cash-secured put and then stock price accelerates substantially, the put value will decline. Share price and put value are inversely-related. This allows us to take advantage of our 20%/10% put-selling guidelines exit strategy discussed on pages 141 – 143 of my book, Selling Cash-Secured Puts. With this exit strategy, if […]
Why Was My Short Out-Of-The-Money Put Exercised?
When we sell covered calls or cash-secured puts, we understand that if a strike ends up in-the-money at expiration, that option will be exercised over the weekend and shares will be sold or purchased depending on the option type (for calls, our shares are sold; for puts, new shares are purchased with the cash set […]
Converting a Covered Call Trade to a Collar Trade: An Analysis Using ALXN
When we sell and in-the-money or at-the-money strike and share price moves up substantially, we have an unrealized maximum return. On 4/5/2019, Doug wrote to me about such a situation he was in with Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). He was considering buying a protective put to protect part of the unrealized profit and thought […]
Stock Selection: Using Secondary Parameters from Our Premium Stock Reports
Stock selection is the first of 3-required skills essential to become an elite option-seller. Option selection and position management are the other two. On 3/31/2019, Sunny wrote to me inquiring about 2 stocks, Edwards Lifesciences Corp. (NASDAQ: EW) and Regeneron Pharmaceuticals (NASDAQ: REGN). He was deciding between these 2 securities in the “medical industry” and […]
Can We Manage Our In-The-Money Strikes to Create a No-Risk Investment Strategy?
Covered call writing is a low-risk cash-generating strategy. It is not a no-risk strategy. As we become educated and master the 3-required skills (stock selection, option selection and position management), it is understandable why BCI members try to figure out strategies that can convert low-risk to no-risk. Here is a common inquiry I receive from […]
Timing Our Covered Call Trades: The Best Time to Sell Our Options After Buying the Stock
The goals of covered call writing include generating monthly cash flow and preserving capital. We use every fundamental, technical and common-sense principle available to maximize our profits and protect our cash. Paul A. previously sent me an excellent question that motivated this article: …if the market has a down day and drags down the price […]
“Hitting a Double” with XBI: Earn $100 in Four Minutes
Position management (exit strategies) is one of the 3-required skills for successful covered call writing and put-selling. “Hitting a double” involves buying back the short call using our 20%/10% guidelines and then re-selling that same option when share price recovers. On 3/13/2019, Mario was kind enough to share with us his trades with SPDR S&P Biotech […]
